Home/Specialties/Plastic & Reconstructive Surgery

Practice · Plastic & Reconstructive Surgery

Reconstructive-first positioning that earns aesthetic trust downstream.

We build burn, oncoplastic-breast and microsurgical funnels as the trust foundation — then layer ethically-communicated aesthetic programmes on top.

For Chiefs of Plastic Surgery, Reconstructive Program Heads and MDs of super-specialties with dedicated plastics units.

Request a Plastic Surgery Pipeline Blueprint →Review case evidence

Reconstructive Case Mix

62%

of total plastics volume

Microsurgery Volume

+3.1×

12-month cohort

Oncoplastic Referrals

+240%

onco-MDT integration

OT Utilization

78%

plastics block

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

Burn Reconstruction

₹2.4 L–6.5 L

Post-acute burn referral pathway

Oncoplastic Breast (with Onco)

₹2.8 L–5.5 L

Breast-cancer MDT pathway

Microsurgery / Free Flaps

₹4.5 L–12 L

Complex reconstructive referral

Rhinoplasty (Functional + Aesthetic)

₹1.4 L–3.2 L

Septoplasty + aesthetic dual funnel

Body Contouring (Post-Bariatric)

₹1.8 L–4.2 L

Bariatric-integrated pathway

Gender-Affirming Surgery

₹3.5 L–14 L

Long-cycle multi-disciplinary programme

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom, condition and referrer-based intent capture across catchment.
02 · Clinical triage
Specialty-trained nurse/coordinator triage with report upload before consult.
03 · Consultant handoff
Calendar-synced booking to the operating consultant with pre-read notes.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

3.1× microsurgery volume, 62% reconstructive case mix.

A representative RDV engagement in the Plastic & Reconstructive Surgery practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: Plastics unit inside multi-specialty tertiary, 40 beds
Duration: 12 months
Cohort: n = 780 medically-referred cases
Outcome: 3.1× microsurgery volume, 62% reconstructive case mix

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of Plastic Surgery choose RDV

Trust is earned in the operating logic, not the pitch deck.

Reconstructive-first brand

Reconstructive work is the trust anchor. Aesthetic communication is layered on top — never leading. Category-defining positioning.

Onco-MDT integration

Oncoplastic breast programmes co-run with surgical oncology MDT — clinical continuity, not siloed referrals.

Realistic-expectation counselling

Every aesthetic enquiry gets a documented expectation-setting conversation before consult. Attrition at this gate protects your brand.

WPATH-aligned gender-affirming pathway

Long-cycle multi-disciplinary programmes with mental-health, endocrine and surgical alignment — the only ethical way to build this line.

From an engagement

"Positioning us as a reconstructive centre first changed the conversation. Aesthetic patients started asking for us because they knew we do the serious work."

— Chief of Plastic Surgery · 40-bed multi-specialty tertiary

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a Plastic Surgery Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

Plastic surgeon reconstructive-decision framework
Oncoplastic breast MDT protocol (with onco)
Ethics-of-aesthetic-communication published position

Compliance posture

Every asset, every claim, medically reviewed.

NMC norms — no before/after imagery without documented consent
No cosmetic outcome guarantees; realistic-expectation counselling mandatory
Gender-affirming care aligned to WPATH SOC-8 guidelines

Catchment note: Metropolitan reconstructive-referrer networks; international corridors for microsurgery and body contouring.

The 21-day diagnostic

What the fixed-scope engagement actually contains — for Plastic Surgery.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
Plastics OT audit; reconstructive vs aesthetic case-mix baseline.
Week 2
Onco, burns-unit and orthopaedic-trauma referrer mapping.
Week 3
Procedure economics; multi-disciplinary programme revenue model.
Week 4
Founder-led blueprint with Chief of Plastic Surgery.

Where we compound

The unfair edge — for Plastic Surgery specifically.

Reconstructive-first brand positioning — rare in category
Onco-MDT-integrated oncoplastic programme operational
WPATH-aligned gender-affirming pathway among the few structured programmes in India

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

Aesthetic marketing drives our revenue — we can't lead with reconstruction.

You can, and you'll charge more for aesthetics because reconstruction anchors clinical credibility. Different order, better economics.

Before/after imagery is standard.

Standard doesn't mean safe. We use consented process imagery and outcome-neutral language. NMC risk goes to zero; brand risk drops with it.

Gender-affirming care is politically sensitive.

Handled through WPATH SOC-8-aligned pathways with mental-health and endocrine integration — the medical framework silences the political noise.

FAQ

The questions Chiefs of Plastic Surgery ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

Can you grow aesthetic volume without before/after ads?+

Yes — via reconstructive-first brand positioning, consented process content and physician-referral pathways. Higher-margin patients, lower churn.

How do you handle oncoplastic integration?+

Co-run with your onco MDT: breast-cancer referrals see plastics at the same MDT slot, generating a documented reconstructive pathway from diagnosis onward.

What about international aesthetic patients?+

Corridor-specific with language calibration, financial pre-authorisation and visa-facilitation. GCC and East Africa already active.

Next step